MRI Contrast Agents and NSF: Websites and Links to Obtain Current Information

American College of Radiology
http://www.acr.org/

http://www.acr.org/SecondaryMainMenuCategories/quality_safety/MRSafety.aspx

The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR)
http://www.icnfdr.org/

International Society for Magnetic Resonance in Medicine
http://ismrm.org/

http://ismrm.org/special/FDA.htm

Medicines and Healthcare products Regulatory Agency
http://www.mhra.gov.uk

United States Food and Drug Administration
http://www.fda.gov/cder/drug/infopage/gcca/qa_20061222.htm

http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm

http://www.fda.gov/bbs/topics/NEWS/2007/NEW01638.html

http://www.fda.gov/cder/drug/infopage/gcca/qa_200705.htm

http://www.fda.gov/cder/drug/infopage/gcca/default.htm

http://www.fda.gov/cder/drug/advisory/gadolinium_agents_20061222.htm

The ACR Contrast Media Guidelines Version 7 was published on line earlier this month and is available for your review and reference at the links noted below.

The URL to link to the website is:

http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspx

Additionally the section linked below has been revised with input and approval of the ACR Subcommittee on MR Safety:

http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual/NephrogenicSystemicFibrosis.aspx

“Reprinted with permission of the American College of Radiology. No other representation is authorized without express permission of the American College of Radiology.”


[*For additional information, please refer to the following comprehensive review Shellock FG, Spinazzi A. MRI Safety Update: 2008, Part 1, MRI contrast agents and nephrogenic systemic fibrosis. American Journal of Roentgenology 2008;191:1-11. This article is available as a free downloadable PDF file at http://www.ajronline.org/]